A review of the device labeling was completed.Elevated iop and pigment dispersion are identified in the labeling as known adverse events from icl implantation.The dfu adequately provides instructions for icl implantation and includes known adverse events associated with lens implantation.The dfu statements include: adverse reactions and complications due to or following surgery and implantation of any evo|evo+icl may include, but are not limited to: uveitis/iritis, iop elevation from baseline, iris pigment dispersion, secondary surgical intervention to remove the lens.Even though the causality was attributed to the device an exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.The lens was not returned to date.H6- health effect- clinical code 4581: pigment dispersion.H6 - type of investigation - lens work order search: no similar complaint type events reported for units within the same lot.Claim# (b)(4).
|